Michael Gold to Quality-Adjusted Life Years
This is a "connection" page, showing publications Michael Gold has written about Quality-Adjusted Life Years.
Connection Strength
0.905
-
Economic Value and Cost-Effectiveness of?Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up. JACC Heart Fail. 2017 03; 5(3):204-212.
Score: 0.526
-
Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care. 1998 Jun; 36(6):778-92.
Score: 0.145
-
Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapy. Heart Fail Clin. 2011 Apr; 7(2):241-50, ix.
Score: 0.088
-
Improving value measurement in cost-effectiveness analysis. Med Care. 2000 Sep; 38(9):892-901.
Score: 0.042
-
Toward a broader view of values in cost-effectiveness analysis of health. Hastings Cent Rep. 1999 May-Jun; 29(3):7-15.
Score: 0.039
-
Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996 Oct 16; 276(15):1253-8.
Score: 0.032
-
The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996 Oct 09; 276(14):1172-7.
Score: 0.032